Perchellet Elisabeth M, Wang Yang, Lou Kaiyan, Zhao Huiping, Battina Srinivas K, Hua Duy H, Perchellet Jean-Pierre H
Anti-Cancer Drug Laboratory, Division of Biology, Ackert Hall, Kansas State University, Manhattan, KS 66506-4901, USA.
Anticancer Res. 2007 Sep-Oct;27(5A):3259-71.
Substituted triptycenes (TT code number), which block nucleoside transport, macromolecule syntheses and DNA topoisomerase activities, induce cytochrome c release and apoptotic DNA fragmentation, inhibit the proliferation of drug-sensitive and -resistant tumor cells in the nM range in vitro and rapidly trigger the collapse of mitochondrial transmembrane potential in cell and cell-free systems. Because mitochondrial permeability transition (MPT) requires more than depolarization, antitumor TTs were tested for their ability to directly trigger specific markers of MPT in isolated mitochondria.
Large amplitude swelling and Ca2+ release were assayed in isolated mitochondria to demonstrate TT-induced MPT.
Antitumor TTs interact with isolated mitochondria in a concentration- and time-dependent manner to rapidly cause large amplitude swelling and Ca2+ release in relation with their antiproliferative activities in L1210, HL-60 and LL/2 tumor cells in vitro. The ability of 4-10 uM TT15, TT16 and TT24 to maximally induce mitochondrial swelling and Ca2+ release within 20 min is similar to that of classic MPT inducers, such as 5 microg/ml alamethicin, 200 microM atractyloside, 5 microM phenylarsine oxide, 100 microM arsenic trioxide and a 100 microM Ca2+ overload. TT15 requires a priming concentration of 20 microM Ca2+ to trigger mitochondrial swelling and Ca2+ release and these 0.1 microM ruthenium red-sensitive MPT events are abolished by 1 microM cyclosporin A, 2 mM ADP and 20 microM bongkrekic acid, which block components of the permeability transition pore (PTP), and by 50-100 microM of various ubiquinones, which interact with the quinone binding site of the PTP and raise the Ca2+ load required for PTP opening.
Antitumor TTs that trigger MPT in isolated mitochondria might interact with components of the PTP to boost its Ca2+-sensitive transition from the closed to the open state and might be valuable to develop mitochondriotoxic drugs that directly activate early components of apoptosis.
取代三联苯(TT 编号)可阻断核苷转运、大分子合成及 DNA 拓扑异构酶活性,诱导细胞色素 c 释放和凋亡性 DNA 片段化,在体外纳摩尔浓度范围内抑制药物敏感和耐药肿瘤细胞的增殖,并在细胞及无细胞系统中迅速引发线粒体跨膜电位的崩溃。由于线粒体通透性转换(MPT)需要的不仅仅是去极化,因此对抗肿瘤 TT 进行了测试,以评估其在分离的线粒体中直接触发 MPT 特异性标志物的能力。
在分离的线粒体中检测大幅度肿胀和 Ca²⁺释放,以证明 TT 诱导的 MPT。
抗肿瘤 TT 以浓度和时间依赖性方式与分离的线粒体相互作用,迅速引起大幅度肿胀和 Ca²⁺释放,这与其在体外 L1210、HL - 60 和 LL/2 肿瘤细胞中的抗增殖活性相关。4 - 10 μM 的 TT15、TT16 和 TT24 在 20 分钟内最大程度诱导线粒体肿胀和 Ca²⁺释放的能力与经典 MPT 诱导剂相似,如 5 μg/ml 短杆菌肽 A、200 μM 苍术苷、5 μM 苯胂酸、100 μM 三氧化二砷和 100 μM Ca²⁺过载。TT15 需要 20 μM Ca²⁺的引发浓度来触发线粒体肿胀和 Ca²⁺释放,这些 0.1 μM 钌红敏感的 MPT 事件被 1 μM 环孢素 A、2 mM ADP 和 20 μM 邦克雷酸消除,它们阻断通透性转换孔(PTP)的成分,以及被 50 - 100 μM 的各种泛醌消除,这些泛醌与 PTP 的醌结合位点相互作用并提高 PTP 开放所需的 Ca²⁺负荷。
在分离的线粒体中触发 MPT 的抗肿瘤 TT 可能与 PTP 的成分相互作用,以促进其对 Ca²⁺敏感的从关闭状态到开放状态的转变,并且可能对开发直接激活凋亡早期成分的线粒体毒性药物有价值。